OKYO Pharma
Biotechnology Research in United Kingdom
Overview
OKYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases.
Tagline
Pioneering Therapies for Neuropathic Corneal Pain and Inflammation. NASDAQ: OKYO
EMPLOYEES
2-10 employees
FOUNDED
2018
HQ
London, England
TYPE
Public Company
Location
- Street
- 55 Park Lane
- City
- London
- Region
- England
- Postal code
- W1K 1QG
- Country
- United Kingdom
Email patterns
See email patterns for OKYO Pharma
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
okyopharma.com is the website of OKYO Pharma.
What is the industry of the company?
OKYO Pharma (okyopharma.com) is in the Biotechnology Research industry.
When was the company founded?
OKYO Pharma (okyopharma.com) was founded in 2018.
How many employees does the company have?
OKYO Pharma (okyopharma.com) has 2-10 employees.
What is the company type?
The company type of OKYO Pharma (okyopharma.com) is Public Company.
Where is the company headquartered?
OKYO Pharma (okyopharma.com) is headquartered in London, England.
What is the address of the company?
The address of OKYO Pharma (okyopharma.com) is 55 Park Lane, London, England, W1K 1QG, United Kingdom.
What are the social media accounts of the company?
The social media account of OKYO Pharma (okyopharma.com) is LinkedIn.
Social media